• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

EP News: Clinical
Yasada et  al (N Engl J Med 2019;381:1103, PMID 31475793) conducted a prospective randomized multicenter trial of 2236 patients with atrial fibrillation (AF) who had undergone percutaneous coronary intervention or coronary artery bypass grafting more than 1 year earlier or who had angiographically confirmed coronary artery disease not requiring revascularization. Patients were randomized to monotherapy with rivaroxaban or combination therapy with rivaroxaban plus a single antiplatelet agent. The primary efficacy end point was a composite of stroke, systemic embolism, myocardial infarction, unstable ang ina requiring revas...
Source: Heart Rhythm - October 27, 2019 Category: Cardiology Authors: N.A. Mark Estes Tags: EP News Source Type: research

Endocardial occlusion of incompletely surgically ligated left atrial appendage using an Amplatzer septal occluder device
A 55-year-old man underwent a surgical Maze procedure for the treatment of nonvalvular atrial fibrillation with concomitant surgical suture ligation of left atrial appendage (LAA). Baseline transesophageal echocardiography (TEE) and computed tomography (CT) angiography revealed a normal LAA free of thrombus (A). Ten days after surgery, he developed an acute embolic stroke. Repeat TEE and CT angiography demonstrated an incompletely surgically ligated LAA (ISLL) without thrombus, with the ISLL neck dimensions measuring 3 × 3 mm (B). He was promptly initiated on oral anticoagulation (OAC) therapy. But owing to intolerance to...
Source: Heart Rhythm - June 24, 2013 Category: Cardiology Authors: Arash Aryana, Sean Bailey, Padraig Gearoid O’Neill, André d’Avila Tags: Image Source Type: research